T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Tesla
TSLA
|
+$1.87B |
| 2 |
T-Mobile US
TMUS
|
+$1.53B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.43B |
| 4 |
Apple
AAPL
|
+$1.28B |
| 5 |
PepsiCo
PEP
|
+$1.1B |
Top Sells
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.16B |
| 2 |
Amazon
AMZN
|
+$3.02B |
| 3 |
GE Aerospace
GE
|
+$2.2B |
| 4 |
Goldman Sachs
GS
|
+$1.76B |
| 5 |
Salesforce
CRM
|
+$1.43B |
Sector Composition
| 1 | Technology | 30.27% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.3% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
BioNTech
BNTX
$25.1B
| $7.59M | ﹤0.01% |
60,913
-723,365
| -92% | -$90.1M |
|
1102
Digital Turbine
APPS
$494M
| $7.3M | ﹤0.01% |
590,509
-173,992
| -23% | -$2.15M |
|
1103
Advanced Drainage Systems
WMS
$11B
| $7.17M | ﹤0.01% |
85,162
+47,831
| +128% | +$4.03M |
|
1104
SLM Corp
SLM
$6.05B
| $7.17M | ﹤0.01% |
578,450
-556,630
| -49% | -$6.9M |
|
1105
Air Lease Corp
AL
$7.11B
| $7.13M | ﹤0.01% |
181,087
+13,000
| +8% | +$512K |
|
1106
Vale
VALE
$45.4B
| $7.12M | ﹤0.01% |
451,140
+65,800
| +17% | +$1.04M |
|
1107
Jabil
JBL
$23.2B
| $7.12M | ﹤0.01% |
80,725
+2,732
| +4% | +$241K |
|
1108
Twilio
TWLO
$15.7B
| $7.07M | ﹤0.01% |
106,124
-6,301
| -6% | -$420K |
|
|
SWTX
1109
DELISTED
SpringWorks Therapeutics
SWTX
| $7.04M | ﹤0.01% |
273,427
+34,774
| +15% | +$895K |
|
1110
NorthWestern Energy
NWE
$3.47B
| $7M | ﹤0.01% |
120,873
+4,274
| +4% | +$247K |
|
1111
Voyager Therapeutics
VYGR
$243M
| $6.95M | ﹤0.01% |
901,465
+104,144
| +13% | +$803K |
|
1112
Zions Bancorporation
ZION
$8.56B
| $6.95M | ﹤0.01% |
232,033
+5,141
| +2% | +$154K |
|
1113
DaVita
DVA
$9.46B
| $6.93M | ﹤0.01% |
85,382
-2,521
| -3% | -$205K |
|
1114
National Bank Holdings
NBHC
$1.47B
| $6.9M | ﹤0.01% |
206,233
+377
| +0.2% | +$12.6K |
|
1115
Immunovant
IMVT
$2.93B
| $6.88M | ﹤0.01% |
443,204
+167,205
| +61% | +$2.59M |
|
1116
RH
RH
$4.27B
| $6.88M | ﹤0.01% |
28,225
-5,166
| -15% | -$1.26M |
|
1117
Cadre Holdings
CDRE
$1.28B
| $6.84M | ﹤0.01% |
317,542
-3,411
| -1% | -$73.5K |
|
|
BCYC
1118
Bicycle Therapeutics
BCYC
$485M
| $6.77M | ﹤0.01% |
318,076
-20,657
| -6% | -$439K |
|
1119
StepStone Group
STEP
$4.99B
| $6.72M | ﹤0.01% |
276,896
+1,389
| +0.5% | +$33.7K |
|
1120
Aura Biosciences
AURA
$412M
| $6.6M | ﹤0.01% |
710,605
-28,610
| -4% | -$266K |
|
1121
Enanta Pharmaceuticals
ENTA
$178M
| $6.58M | ﹤0.01% |
162,694
-11,609
| -7% | -$470K |
|
1122
Knight Transportation
KNX
$6.76B
| $6.49M | ﹤0.01% |
114,589
+2,558
| +2% | +$145K |
|
1123
nCino
NCNO
$3.47B
| $6.44M | ﹤0.01% |
259,827
+1,456
| +0.6% | +$36.1K |
|
1124
SoFi Technologies
SOFI
$31.1B
| $6.4M | ﹤0.01% |
1,053,668
+64,244
| +6% | +$390K |
|
1125
Timken Company
TKR
$5.32B
| $6.39M | ﹤0.01% |
78,230
-4,305
| -5% | -$352K |
|